LSTA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lisata Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.16 USD -19.44% Market Closed

Market Cap: $10.6m

	Lisata Therapeutics Inc NASDAQ:LSTA	US
	Namura Shipbuilding Co Ltd F:8AF	JP
A	Aeterna Zentaris Inc F:ET82	US
W	Williams Companies Inc DUS:WMB	US
	Mitek Systems Inc NASDAQ:MITK	US
	Netstreit Corp F:64N	US
S	Semiconductor Manufacturing International Corp F:MKN2	CN
	Sberbank Rossii PAO MOEX:SBER	RU
A	AfreecaTV Co Ltd KOSDAQ:067160	KR
U	UGI Corp XBER:3U6	US

Profitability Summary

Lisata Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-10 711%

Negative 3Y Average Operating Margin

-3 791%

Negative Net Margin

-9 756%

Negative 3Y Average Net Margin

-3 432%

Negative Free Cash Flow Margin

-9 398%

Negative 3Y Average Free Cash Flow Margin

-3 252%

Negative ROE

-75%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-923%

Declining ROIC

-699% > -1 062%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.